CD82 and sarcoma: In sarcomas, Gp78 interacts with the transmembrane metastasis inhibitor KAI1 (also known as CD82), and inhibition of Gp78 can promote the accumulation of KAI1, lead to apoptosis, and reduce tumor metastasis (Table 1) [58].